Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Phyllis SY Chong"'
Autor:
Jianbiao Zhou, Chonglei Bi, Ying Qing Ching, Jing-Yuan Chooi, Xiao Lu, Jessie Yiying Quah, Sabrina Hui-Min Toh, Zit-Liang Chan, Tuan Zea Tan, Phyllis SY Chong, Wee-Joo Chng
Publikováno v:
Journal of Hematology & Oncology, Vol 10, Iss 1, Pp 1-13 (2017)
Abstract Background Current conventional chemotherapy for acute myeloid leukemia (AML) can achieve remission in over 70% of patients, but a majority of them will relapse within 5 years despite continued treatment. The relapse is postulated to be due
Externí odkaz:
https://doaj.org/article/bb8e3cff02414ed78cf8acad3518d8be
Publikováno v:
Cancer Research. 83:3681-3681
Overexpression of transcription factor c-MAF is found in about 50% of multiple myeloma cases, and associated with the prognostically unfavorable t(14;16) translocation subtype. Genetic alterations can modify the epigenome through metabolite availabil
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::092c0530a2abf6ae5de3aad4c876ffd2
https://doi.org/10.1158/1538-7445.am2023-3681
https://doi.org/10.1158/1538-7445.am2023-3681
Publikováno v:
Experimental Hematology. 111:S69-S70
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::9167f6baa5dd71c2217a1394f0dbba66
https://doi.org/10.1016/j.exphem.2022.07.106
https://doi.org/10.1016/j.exphem.2022.07.106
Publikováno v:
Blood. 138:2202-2202
Multiple Myeloma (MM) is characterized by the uncontrolled proliferation of malignant plasma cells that are incapable of producing functional antibodies. Current treatment regime involves novel drug classes such as proteasome inhibitors, immunomodula
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::2c159f1e225864b39647e83eb2073815
https://doi.org/10.1182/blood-2021-145839
https://doi.org/10.1182/blood-2021-145839